Modified GRF (1-29), GHRP-6 Blend is a synthetic peptide mixture supplied exclusively as a laboratory research material. The formulation combines Modified GRF (1-29), a growth hormone-releasing hormone receptor ligand, with GHRP-6, a growth hormone secretagogue receptor ligand.
The blend may be used in controlled laboratory experiments examining receptor activity, ligand-response relationships, peptide stability, analytical characteristics, and signaling interactions associated with the growth hormone axis. It also provides a defined research material for comparative studies involving individual peptide controls and multi-compound test conditions.
All research involving this material should use validated analytical methods, documented laboratory procedures, and appropriately controlled experimental conditions. Conclusions should remain limited to the specific model, methodology, and measured endpoints used in each study.
Nordsci provides lot-specific analytical documentation to support material verification, quality review, and laboratory recordkeeping. Researchers should consult the applicable Certificate of Analysis for information regarding the identity, purity, and analytical characteristics of the received lot.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Modified GRF (1-29), GHRP-6 Blend is supplied as a lyophilized research material for controlled laboratory and analytical applications. The formulation combines Modified GRF (1-29), a synthetic peptide associated with growth hormone-releasing hormone receptor research, and GHRP-6, a synthetic peptide associated with growth hormone secretagogue receptor research.
The blend may be incorporated into validated experimental systems examining receptor activity, ligand-response relationships, peptide characteristics, assay behavior, and signaling interactions associated with the growth hormone axis. It also provides a defined material for comparative protocols involving individual peptide controls and combined-compound test conditions.
All findings should be interpreted within the limits of the experimental model, analytical method, control structure, and measured endpoints. Research observations must not be extrapolated into claims regarding safety, efficacy, or suitability for use in humans or animals.
Modified GRF (1-29), GHRP-6 Blend – Research Specifications:
| Product Name | Modified GRF (1-29), GHRP-6 Blend |
| Contents | Modified GRF (1-29) and GHRP-6 |
| Format | Lyophilized peptide blend |
| Appearance | Lyophilized powder |
| Purity / Identity | Refer to the lot-specific Certificate of Analysis for applicable analytical data |
| Testing Documentation | Lot-specific analytical documentation is available for laboratory review |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture. Follow the product label, lot documentation, and applicable laboratory SOPs. |
| Research Use Only | Supplied exclusively for laboratory research and analytical testing. Not for human or animal consumption. |
Modified GRF (1-29) is a synthetic peptide used in controlled research involving growth hormone-releasing hormone receptor activity. Laboratory investigations may examine receptor interactions, signaling kinetics, assay responses, peptide stability, and related biochemical measurements under predefined conditions.
GHRP-6 is a synthetic hexapeptide used in research involving the growth hormone secretagogue receptor. Investigators may evaluate this material through receptor-binding assays, analytical characterization, biochemical experiments, and other validated laboratory systems designed to measure ligand-response relationships.
Combining the two research materials allows investigators to examine distinct receptor-associated inputs within one experimental condition. Depending on the study design, the blend may be evaluated alongside individual Modified GRF (1-29) and GHRP-6 controls, vehicle controls, reference materials, or other predefined test conditions.
Researchers examining the individual materials may reference the product pages for CJC-1295 (without DAC) , commonly identified in research-supply contexts as Modified GRF (1-29), and GHRP-6 .
Important Research Notice: Nordsci products include lot-level analytical documentation for material verification, laboratory recordkeeping, and quality review. Researchers should consult the applicable Certificate of Analysis before incorporating the material into an experimental protocol.
FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT INTENDED FOR CLINICAL, DIAGNOSTIC, THERAPEUTIC, VETERINARY, FOOD, COSMETIC, OR DIETARY-SUPPLEMENT USE.
Controlled laboratory models may use this blend to examine measurable signaling patterns associated with two distinct peptide-receptor systems. Study designs should incorporate predefined sampling intervals, validated analytical methods, and appropriate experimental controls.
The formulation may be incorporated into research models examining signaling relationships associated with the growth hormone axis. Model-specific endpoints may include receptor activity, biochemical markers, temporal response patterns, or other defined laboratory measurements.
Researchers may use validated analytical procedures to measure selected biomarkers under controlled test conditions. Any observed measurement should be interpreted within the limitations of the assay, research model, sampling procedure, and experimental protocol.
The blend may be evaluated alongside individual Modified GRF (1-29) and GHRP-6 test conditions. Comparative protocols can help researchers distinguish measurements associated with an individual compound from those recorded under a combined experimental condition.
Modified GRF (1-29), GHRP-6 Blend should be handled only by qualified laboratory personnel using established procedures for synthetic research materials. Laboratories should document receipt, storage, handling, sample preparation, testing conditions, and disposal according to internal protocols and applicable requirements.
Protocol Design Considerations: Experimental designs should account for assay sensitivity, material concentration, control selection, sampling intervals, environmental conditions, batch identity, and other variables that could affect measurement consistency. The applicable Certificate of Analysis should be reviewed as part of material qualification and laboratory documentation.
Note: This information is provided exclusively as a laboratory research reference. It does not provide dosing, administration, clinical-application, veterinary-use, or human-use guidance.
Lot-specific Certificates of Analysis provide analytical information associated with the tested batch. Depending on the applicable report, documentation may include identity, purity, test methodology, and other quality-related data.
Researchers should match the lot number displayed on the product label with the corresponding Certificate of Analysis. The report should be retained with procurement records, inventory documentation, and experimental files when required by the laboratory’s quality system.
Qualified laboratories sourcing Modified GRF (1-29), GHRP-6 Blend should evaluate product identity, lot traceability, analytical documentation, storage requirements, and supplier quality-control practices.
Nordsci Peptides supplies this blend as a laboratory research material with lot-specific analytical documentation available for review. Purchasers are responsible for determining whether the material is appropriate for their authorized research activities and for complying with applicable institutional, local, state, and federal requirements.
IMPORTANT: This product is supplied exclusively for laboratory research and analytical testing. It is not for human or animal consumption and is not intended for clinical, diagnostic, therapeutic, veterinary, food, cosmetic, or dietary-supplement use. No dosing, administration, or application guidance is provided.
